Spanish Red Biotech Pipeline

AbbVie

Epcoritamab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: "First-line Large B-cell Lymphoma US , EU Relapsed ∕ Refractory Follicular Lymphoma N ∕ A B-cell Non-Hodgkin lymphoma N ∕ A Relapsed ∕ Refractory Chronic Lymphocytic Leukemia N ∕ A Richter's Syndrome"
Phase: 3Phase III in Spain, 2Phase II, 1Phase I